These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

494 related articles for article (PubMed ID: 26162474)

  • 1. Detection of triazole resistance among Candida species by matrix-assisted laser desorption/ionization-time of flight mass spectrometry (MALDI-TOF MS).
    Saracli MA; Fothergill AW; Sutton DA; Wiederhold NP
    Med Mycol; 2015 Sep; 53(7):736-42. PubMed ID: 26162474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rapid detection of fluconazole resistance in Candida tropicalis by MALDI-TOF MS.
    Paul S; Singh P; A S S; Rudramurthy SM; Chakrabarti A; Ghosh AK
    Med Mycol; 2018 Feb; 56(2):234-241. PubMed ID: 28992333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antifungal susceptibilities of Candida glabrata species complex, Candida krusei, Candida parapsilosis species complex and Candida tropicalis causing invasive candidiasis in China: 3 year national surveillance.
    Xiao M; Fan X; Chen SC; Wang H; Sun ZY; Liao K; Chen SL; Yan Y; Kang M; Hu ZD; Chu YZ; Hu TS; Ni YX; Zou GL; Kong F; Xu YC
    J Antimicrob Chemother; 2015 Mar; 70(3):802-10. PubMed ID: 25473027
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proof of Concept for MBT ASTRA, a Rapid Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry (MALDI-TOF MS)-Based Method To Detect Caspofungin Resistance in Candida albicans and Candida glabrata.
    Vatanshenassan M; Boekhout T; Lass-Flörl C; Lackner M; Schubert S; Kostrzewa M; Sparbier K
    J Clin Microbiol; 2018 Sep; 56(9):. PubMed ID: 30021820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiology of candidemia in Qatar, the Middle East: performance of MALDI-TOF MS for the identification of Candida species, species distribution, outcome, and susceptibility pattern.
    Taj-Aldeen SJ; Kolecka A; Boesten R; Alolaqi A; Almaslamani M; Chandra P; Meis JF; Boekhout T
    Infection; 2014 Apr; 42(2):393-404. PubMed ID: 24352810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multidrug-Resistant Candida auris Misidentified as Candida haemulonii: Characterization by Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry and DNA Sequencing and Its Antifungal Susceptibility Profile Variability by Vitek 2, CLSI Broth Microdilution, and Etest Method.
    Kathuria S; Singh PK; Sharma C; Prakash A; Masih A; Kumar A; Meis JF; Chowdhary A
    J Clin Microbiol; 2015 Jun; 53(6):1823-30. PubMed ID: 25809970
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Rapid identification and susceptibility testing of Candida spp. from positive blood cultures by combination of direct MALDI-TOF mass spectrometry and direct inoculation of Vitek 2.
    Idelevich EA; Grunewald CM; Wüllenweber J; Becker K
    PLoS One; 2014; 9(12):e114834. PubMed ID: 25489741
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Candida and candidaemia. Susceptibility and epidemiology.
    Arendrup MC
    Dan Med J; 2013 Nov; 60(11):B4698. PubMed ID: 24192246
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changing epidemiology of candidaemia in Australia.
    Chapman B; Slavin M; Marriott D; Halliday C; Kidd S; Arthur I; Bak N; Heath CH; Kennedy K; Morrissey CO; Sorrell TC; van Hal S; Keighley C; Goeman E; Underwood N; Hajkowicz K; Hofmeyr A; Leung M; Macesic N; Botes J; Blyth C; Cooley L; George CR; Kalukottege P; Kesson A; McMullan B; Baird R; Robson J; Korman TM; Pendle S; Weeks K; Liu E; Cheong E; Chen S;
    J Antimicrob Chemother; 2017 Apr; 72(4):1103-1108. PubMed ID: 28364558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MALDI-TOF typing highlights geographical and fluconazole resistance clusters in Candida glabrata.
    Dhieb C; Normand AC; Al-Yasiri M; Chaker E; El Euch D; Vranckx K; Hendrickx M; Sadfi N; Piarroux R; Ranque S
    Med Mycol; 2015 Jun; 53(5):462-9. PubMed ID: 25841053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Candida infanticola and Candida spencermartinsiae yeasts: Possible emerging species in cancer patients.
    Shokohi T; Aslani N; Ahangarkani F; Meyabadi MF; Hagen F; Meis JF; Boekhout T; Kolecka A; Badali H
    Microb Pathog; 2018 Feb; 115():353-357. PubMed ID: 29292174
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [In vitro activity of fluconazole, voriconazole and posaconazole against Candida spp].
    Rubio Calvo MC; Gil J; Ramírez de Ocáriz I; Benito R; Rezusta A
    Rev Esp Quimioter; 2003 Jun; 16(2):227-32. PubMed ID: 12973462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Candida tropicalis is the most prevalent yeast species causing candidemia in Algeria: the urgent need for antifungal stewardship and infection control measures.
    Megri Y; Arastehfar A; Boekhout T; Daneshnia F; Hörtnagl C; Sartori B; Hafez A; Pan W; Lass-Flörl C; Hamrioui B
    Antimicrob Resist Infect Control; 2020 Apr; 9(1):50. PubMed ID: 32264966
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid antifungal susceptibility testing by matrix-assisted laser desorption ionization-time of flight mass spectrometry analysis.
    Vella A; De Carolis E; Vaccaro L; Posteraro P; Perlin DS; Kostrzewa M; Posteraro B; Sanguinetti M
    J Clin Microbiol; 2013 Sep; 51(9):2964-9. PubMed ID: 23824764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Investigating Antifungal Susceptibility in
    Delavy M; Dos Santos AR; Heiman CM; Coste AT
    Front Cell Infect Microbiol; 2019; 9():19. PubMed ID: 30792970
    [TBL] [Abstract][Full Text] [Related]  

  • 16. International and multicenter comparison of EUCAST and CLSI M27-A2 broth microdilution methods for testing susceptibilities of Candida spp. to fluconazole, itraconazole, posaconazole, and voriconazole.
    Espinel-Ingroff A; Barchiesi F; Cuenca-Estrella M; Pfaller MA; Rinaldi M; Rodriguez-Tudela JL; Verweij PE
    J Clin Microbiol; 2005 Aug; 43(8):3884-9. PubMed ID: 16081926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular characterization and antifungal susceptibility testing of Candida nivariensis from blood samples - an Iranian multicentre study and a review of the literature.
    Arastehfar A; Daneshnia F; Salehi MR; Zarrinfar H; Khodavaisy S; Haas PJ; Roudbary M; Najafzadeh MJ; Zomorodian K; Charsizadeh A; Brouwer C; Pan W; Hagen F; Boekhout T
    J Med Microbiol; 2019 May; 68(5):770-777. PubMed ID: 30924763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anidulafungin Susceptibility Testing of Candida glabrata Isolates from Blood Cultures by the MALDI Biotyper Antibiotic (Antifungal) Susceptibility Test Rapid Assay.
    Vatanshenassan M; Arastehfar A; Boekhout T; Berman J; Lass-Flörl C; Sparbier K; Kostrzewa M
    Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31285227
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology and antifungal susceptibility testing of non-albicansCandida species colonizing mucosae of HIV-infected patients in Yaoundé (Cameroon).
    Ngouana TK; Toghueo RMK; Kenfack IF; Lachaud L; Nana AK; Tadjou L; Kouanfack C; Boyom FF; Bertout S
    J Mycol Med; 2019 Sep; 29(3):233-238. PubMed ID: 31204235
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [In vitro activities of posaconazole, fluconazole, itraconazole, ketoconazole and voriconazole against Candida glabrata].
    Blanco MT; Cañadas J; García-Martos P; Marín P; García-Tapia A; Rodríguez J
    Rev Esp Quimioter; 2009 Sep; 22(3):139-43. PubMed ID: 19662547
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.